Checked.be
Active
BE 0736.366.194Private limited company
LIDENT
Kerkstraat 32 ·2275 Lille, Belgium· 6 yrs active
Sector: Dental practice
(86230)
Conclusion
LIDENT has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €22k and a net result of €13k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 6% of 2244 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Based on the State Gazette, CBE and 5 annual accounts.
Key figures
| Equity | €22k |
| Net result | €13k |
| Staff (FTE) | 4.9 |
| Better than sector | 6% |
Financial profile
64
/ 100
Strong profile, led by profitability.
All 5 axes are computed from data Checked has read.
Health
43
Profitability
100
Solvency
1
Growth
78
Stability
100
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
More than 3 years active
Founded in 2019, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
43
/ 100
Weak
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
€1k
estimate, not credit advice
Score history
23
2021
44
2022
25
2023
51
2024
43
2025
purely financial, excl. current insolvency signals
Score components
Liquidity
Current ratio 0.29 (< 1.0)
-10
Quick ratio
Quick ratio 0.29 (< 0.6)
-5
Leverage
Debt/equity 67.04 (> 3.0)
-10
Profitability
ROE 59% (≥ 10%)
+10
Interest coverage
Interest coverage 36.0× (≥ 3×)
+8
Profit trend
Net profit down YoY
-3
Equity growth
Equity growing YoY
+3
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Financial overview
Annual accounts filed on 28-08-2026 with the NBB · fiscal year 2025 · abbreviated schema
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
volatile
Too volatile to project: the yearly deviation from the trend is ~41% of the level (threshold 35%). We therefore deliberately show no projection line.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2025 · NACE 86, Human health activities · compared within the same schema type (abbreviated schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 1.5% | 59.8% | |
| Net result | €13k | €121k | |
| Equity | €22k | €395k | |
| Gross operating margin | €440k | €301k | |
| Staff costs | €210k | €111k |
€229k
+0.4%
21-25
€13k
-15.0%
21-25
€217k
-0.4%
21-25
€1.46M
-11.0%
21-25
€22k
+141.9%
21-25
€-505k
-16.4%
21-25
5
+32.4%
21-25
€210k
+29.4%
21-25
€6k
+42.9%
21-25
€1.44M
-11.8%
21-25
€709k
+7.5%
21-25
€681k
-21.8%
21-25
0.29
-16.0%
21-25
0.29
-16.0%
21-25
1.5%
+171.7%
21-25
67.04
-63.5%
21-25
58.7%
-64.9%
21-25
0.9%
-4.5%
21-25
36.04
+1.5%
21-25
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Deposit | abbreviated schema | abbreviated schema | abbreviated schema | abbreviated schema | abbreviated schema |
| Revenue | - | - | - | - | - |
| EBITDA | €229k | €228k | €194k | €207k | €204k |
| Net profit | €13k | €15k | €-15k | €405 | €-5k |
| Cash flow | €217k | €218k | €187k | €201k | €195k |
| Staff costs | €210k | €162k | €154k | €122k | €130k |
| Income taxes | €6k | €4k | - | - | - |
| Dividends | - | - | - | - | - |
| Total assets | €1.46M | €1.65M | €1.77M | €2.01M | €2.06M |
| Equity | €22k | €9k | €-6k | €9k | €8k |
| Debt | €1.44M | €1.64M | €1.77M | €2.00M | €2.06M |
| of which ≤ 1y | €709k | €660k | €662k | €642k | €614k |
| of which > 1y | €681k | €871k | €1.06M | €1.25M | €1.44M |
| Working capital | €-505k | €-434k | €-493k | €-433k | €-541k |
| Employees (FTE) | 4.9 | 3.7 | 3.4 | 2.9 | 2.6 |
Ratios (computed)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Current ratio | 0.29 | 0.34 | 0.25 | 0.33 | 0.12 |
| Quick ratio | 0.29 | 0.34 | 0.25 | 0.33 | 0.12 |
| Working capital ratio | -34.5% | -26.4% | -27.9% | -21.6% | -26.2% |
| Solvency | 1.5% | 0.5% | -0.3% | 0.4% | 0.4% |
| Debt / equity | 67.04 | 183.91 | -297.96 | 226.01 | 243.42 |
| Long-term debt ratio | 31.64 | 97.88 | -178.09 | 141.37 | 170.67 |
| Interest coverage | 36.04 | 35.52 | 29.15 | 30.34 | 24.64 |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| ROA | 0.9% | 0.9% | -0.8% | 0.0% | -0.2% |
| ROE | 58.7% | 167.0% | 248.5% | 4.6% | -54.2% |
| EBITDA margin | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - |
| Days inventory (DSI) | - | - | - | - | - |
Balance-sheet composition 2025
Full annual accounts (25 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Balance sheet, Assets | ||||||
| TOTAL ASSETS | 20/58 | €1.46M | €1.65M | €1.77M | €2.01M | €2.06M |
| Fixed assets | 21/28 | €1.26M | €1.42M | €1.60M | €1.80M | €1.99M |
| Intangible fixed assets | 21 | €798k | €988k | €1.18M | €1.37M | €1.56M |
| Tangible fixed assets | 22/27 | €62k | €31k | €23k | €31k | €32k |
| Financial fixed assets | 28 | €400k | €400k | €400k | €400k | €400k |
| Current assets | 29/58 | €204k | €226k | €168k | €209k | €73k |
| Amounts receivable within one year | 40/41 | €147 | €0 | €9k | - | €42k |
| Cash & bank | 54/58 | €196k | €218k | €152k | €209k | €30k |
| Balance sheet, Equity & liabilities | ||||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.46M | €1.65M | €1.77M | €2.01M | €2.06M |
| Equity | 10/15 | €22k | €9k | €-6k | €9k | €8k |
| Contributions / capital | 10/11 | €5k | €5k | €5k | €5k | €5k |
| Reserves | 13 | €17k | €4k | €4k | €4k | €9k |
| Accumulated profits (losses) | 14 | - | €0 | €-15k | - | €-5k |
| Amounts payable | 17/49 | €1.44M | €1.64M | €1.77M | €2.00M | €2.06M |
| Amounts payable after one year | 17 | €681k | €871k | €1.06M | €1.25M | €1.44M |
| Amounts payable within one year | 42/48 | €709k | €660k | €662k | €642k | €614k |
| Trade debts payable within one year | 44 | €75k | €51k | €52k | €33k | - |
| Income statement | ||||||
| Gross operating margin | 9900 | €440k | €393k | €349k | €331k | €334k |
| Operating result | 9901 | €24k | €25k | €-8k | €7k | €4k |
| Financial income | 75 | €265 | €331 | €0 | €78 | - |
| Financial charges | 65 | €6k | €6k | €7k | €7k | €8k |
| Result before taxes | 9903 | €18k | €19k | €-15k | €405 | €-5k |
| Income taxes | 67/77 | €6k | €4k | - | - | - |
| Net result for the period | 9904 | €13k | €15k | €-15k | €405 | €-5k |
| Result to be appropriated | 9905 | €13k | €15k | €-15k | €405 | €-5k |
Legal Structure
| NACE primary | Dental practice(86230) |
| Legal form | Private limited company(610) |
| Incorporation | 14-10-2019 |
| Status | Active |
| Postal code | 2275 |
Establishment units
LIDENT
since 20192.294.606.462
Real-estate footprint
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13019E0734/00C000 | Flanders | 427 m² | 1 · 211 m² | 11.4 m · 2 fl. |
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
Next filing, fiscal year 2026, expected by
2026
28-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 28 days late
2025
10-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Back to profitnet €15k
Net result €15k after one loss-making year.
28-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 28 days late
2023
31-12
Financial
Weakest financial yearnet €-15k ▼3753%
Net result drops to €-15k, the lowest in the series; recovery starts the following year.
27-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 27 days late
2022
31-12
Financial
Back to profitnet €405
Net result €405 after one loss-making year.
29-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 29 days late
2021
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Belgian State Gazette reading coverage
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Credit advice
Company registry (CBE)
Activities
Dental practice86230
Names & trade names
| Legal nameNL | LIDENT |
Similar companies
DENTAPROTHÈSE
BE 0749.522.265 · Namur
Agnes Kintzinger
BE 0657.916.356 · Elsene
Dentimpono
BE 0805.039.127 · Antwerpen
HD DENTAL
BE 0658.734.720 · Charleroi
BOCHICO
BE 0805.131.870 · Ham-sur-Heure-Nalinnes